Losartan decreases hemoglobin in renal transplant recipients

Transplantation Proceedings

Volumn 29, Issue 5, 1997, Pages 2402-2403

  Ducloux, D ^a   Chalopin, J M ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN;

CONFERENCE PAPER; DRUG EFFECT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIPHENYL COMPOUNDS; HEMOGLOBINS; HUMANS; IMIDAZOLES; KIDNEY TRANSPLANTATION; LOSARTAN; TETRAZOLES;

EID: 0030771926     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00420-X     Document Type: Conference Paper

References (10)

1. Loftus WK, Ierino F, Mathew TH: Med J Aus 148:209, 1988 (letter)
2. Sizeland PCB, Bailey RR, Lynn KL, et al: J Cardiovasc Pharmacol 16(suppl):S117, 1990
3. Vlahakos DV, Canzanello VJ, Madaio MP, et al: Am J Kidney Dis 17:199, 1991
4. Gaston RS, Julian BA, Curtis JJ: Am J Kidney Dis 24:1, 1994
5. Johnston CI: Lancet 346:1403, 1995
6. Hirakata H, Onoyama K, Hori K, et al: Clin Nephrol 26:27, 1986
7. Hirakata H, Onoyama K, Iseki K, et al: Am J Nephrol 4:355, 1984
8. Kamper AL, Nielsen OJ: Scand J Clin Lab Invest 50:611, 1990
9. Shand BI: J Hum Hypertens 9:233, 1995
10. Shaw W, Keane W, Sica D, et al: J Am Soc Nephrol 5:567, 1994